This finding is clinically meaningful because it suggests that the risk may accumulate over time. Given that many individuals use these medications chronically, whether for blood sugar control or for weight loss, the long-term ocular safety of GLP-1 RAs requires further investigation, he continued
10.1016/j.brainres.2005.04.069 35 LengsfeldS.BurkardT.MeienbergA.JeanlozN.VukajlovicT.BolognaK.et al (2023)
George Tidmarsh, director of the FDA's Center for Drug Evaluation and Research, said
A semaglutide-glycine compound should be clear and colorless
How long does it typically take for Semaglutide GLP-1 to start suppressing appetite
These changes dont just affect appearance they can also increase the risk of cardiovascular disease, diabetes, and other chronic conditions